FS Development Corp. (FSDC) is a public company listed on NASDAQ. There were no new wire items for FSDC in the last 30 days. The most recent was published Mar 15, 2021.
Latest news
25 items- INSIDERSEC Form 4 filed by Tuyen Ong4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 4 filed by Charles David Lubner4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 4 filed by Walter Strapps4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3 filed by Walter Strapps3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 4 filed by Precillia Redmond4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 4 filed by Scott Lauder4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SECSEC Form 8-K filed8-K - Gemini Therapeutics, Inc. /DE (0001816736) (Filer)
- 13D/GSEC Form SC 13D filedSC 13D - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- INSIDERSEC Form 3 filed by Brian Piekos3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- 13D/GSEC Form SC 13D filedSC 13D - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- 13D/GSEC Form SC 13D filedSC 13D - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- INSIDERSEC Form 3: Llc Associates, Lsv claimed ownership of 4,836,106 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3: Jean George claimed ownership of 4,836,106 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- 13D/GSEC Form SC 13G filedSC 13G - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- 13D/GSEC Form SC 13D filedSC 13D - Gemini Therapeutics, Inc. /DE (0001816736) (Subject)
- SECSEC Form 8-K filed8-K - Gemini Therapeutics, Inc. /DE (0001816736) (Filer)
- INSIDERSEC Form 3: L.P. X, Fund Venture Atlas claimed ownership of 5,254,365 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3: P Jason Rhodes claimed ownership of 5,254,365 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3: Llc Advisors Orbimed claimed ownership of 5,826,224 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3: L Carl Gordon claimed ownership of 5,826,224 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3 filed by Marc Uknis3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3 filed by Precillia Redmond3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3 filed by Tuyen Ong3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- INSIDERSEC Form 3 filed by Patrick Jason Meyenburg3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
FSDC FAQ
6 questionsWhat is the latest news on FSDC?
Quantisnow has not tracked any new filings, ratings or press releases for FSDC in the last 30 days. The most recent wire item was published on March 15, 2021.Where does FSDC stock trade?
FS Development Corp. (FSDC) is listed on NASDAQ.What sector and industry is FSDC in?
FS Development Corp. operates in the n/a sector.When did FS Development Corp. go public?
FS Development Corp. (FSDC) completed its IPO in 2020.What companies are similar to FSDC?
Notable peers in the same industry include HCXY (Hercules Capital, Inc.), ACCP (Accelerated Pharma, Inc.), ACLL (ACell, Inc.), DWEQ (AdvisorShares Dorsey Wright Alpha Equal Weight ETF), DWAW (AdvisorShares Dorsey Wright FSM All Cap World ETF). Compare FSDC side-by-side with any of them on Quantisnow.How can I track FSDC on Quantisnow?
Quantisnow aggregates FS Development Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FSDC to receive live email and push alerts on every new disclosure.